Shotgun Glycomics: Linking Glycan Structure and Function

鸟枪糖组学：连接聚糖结构和功能

• 批准号: 7515462
• 负责人: David Fletcher Smith
• 金额: $ 29.45万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7515462
• 关键词: Age; Binding Proteins; Biological; Cells; Chemical Structure; Chemicals; Chemistry; Development; Disease; Future; Glycoconjugates; Glycoproteins; Human; Human Biology; Human Genome; Knowledge; Libraries; Link; Methods; Natural Immunity; Polysaccharides; Post-Translational Protein Processing; Printing; Process; Relative (related person); Resistance to infection; Resources; Shotguns; Solutions; Structure; Tissues; functional group; glycosylation; novel; novel strategies; pathogen; response; size

DESCRIPTION (provided by applicant): The diversity and size of the human glycome is unknown. Recent studies have revealed that the human genome encodes thousands of glycoproteins, and that glycosylation is likely the most common type of post-translational modification. But how many different glycans are there? What are their relative levels of expression? Does each glycan structure have a function, either in human biology or in disease processes, such as innate immunity and resistance to infection? How does glycan expression change in response to age and disease? It has been known for decades that different cells and tissues make different glycan structures, and recent advances in methods for analysis of glycan structures has led to modern glycomics, which is mainly devoted to identifying glycan structures. Unfortunately, while knowing chemical structures is important, in a sense it only confirms what we already know; different cells make different glycan structures. While knowledge of all glycan structures may solve a chemical puzzle, it does not provide a biological solution to glycan function. We propose a new glycomic approach to link glycan structure to function/recognition using our new developments in "glyco-chemistry" that allow us to fluorescently tag free glycans released from specific cell or tissue glycoconjugates. These novel, bifunctional, fluorescent tags allow us to detect sub-microgram quantities of glycans that are otherwise undetectable, and purify them by chromatographic methods to obtain tissue- and/or cell- specific tagged-glycan libraries (TGLs). The tagged glycans retain a functional group to allow covalent "printing" of these libraries as microarrays. Such microarrays can subsequently be interrogated with glycan binding proteins (GBPs), pathogens, and cells to identify functionally recognized and biologically significant glycans, which will then be structurally defined. This novel approach avoids the laborious process of defining all glycan structures in a glycome regardless of their functional or recognition, and allows us to focus structural analyses on potentially biological relevant glycans. Developing glycomic TGLs is analogous to the "Shotgun" approach to defining the human genome, but allows us to target our analyses to link glycan structure to function. Defining all of the glycan structures of the human glycome is analogous to sequencing the human genome. The complexity of the human glycome and the lack of automated glycan sequencing methods make a "brute-force" approach to defining the glycome impractical. Here we propose a paradigm- shifting strategy, which is a combination of "shotgun" and targeted approaches. We will assemble amino functionalized, fluorescent-tagged glycan libraries from specific cells or tissues, print them as glycan microarrays, identify potentially biologically relevant glycans that are recognized by glycan binding proteins, and structurally define the recognized glycans. The stable, libraries and glycan microarrays produced will remain as a tangible resource for future analyses of both glycan structure and function.

性状（由申请方提供）：人糖组的多样性和大小未知。最近的研究表明，人类基因组编码数千种糖蛋白，糖基化可能是最常见的翻译后修饰类型。但到底有多少种不同的聚糖呢？它们的相对表达水平如何？每种聚糖结构在人类生物学或疾病过程中是否都有功能，如先天免疫和抗感染？聚糖表达如何响应年龄和疾病而变化？几十年来，人们已经知道不同的细胞和组织产生不同的聚糖结构，并且用于分析聚糖结构的方法的最新进展已经导致了现代糖组学，其主要致力于鉴定聚糖结构。不幸的是，虽然知道化学结构很重要，但从某种意义上说，它只能证实我们已经知道的东西;不同的细胞产生不同的聚糖结构。虽然所有聚糖结构的知识可以解决化学难题，但它并不能为聚糖功能提供生物学解决方案。我们提出了一种新的糖组学方法，将聚糖结构与功能/识别联系起来，使用我们在“糖化学”方面的新进展，使我们能够荧光标记从特定细胞或组织糖缀合物释放的游离聚糖。这些新颖的双功能荧光标签允许我们检测亚微克量的聚糖，这些聚糖在其他情况下是不可检测的，并且通过色谱方法纯化它们以获得组织和/或细胞特异性标记的聚糖文库（TGL）。标记的聚糖保留官能团以允许这些文库共价“印刷”为微阵列。随后可以用聚糖结合蛋白（GBP）、病原体和细胞询问这样的微阵列，以鉴定功能上识别的和生物学上重要的聚糖，然后将其结构上定义。这种新方法避免了定义糖组中所有聚糖结构的费力过程，而不管其功能或识别，并使我们能够将结构分析集中在潜在的生物相关聚糖上。开发糖组TGL类似于定义人类基因组的“猎枪”方法，但允许我们将分析目标定位为将聚糖结构与功能联系起来。 定义人类糖组的所有聚糖结构类似于对人类基因组进行测序。人类糖组的复杂性和自动化聚糖测序方法的缺乏使得定义糖组的“蛮力”方法不切实际。在这里，我们提出了一个范式转换战略，这是一个组合的“猎枪”和有针对性的方法。我们将从特定的细胞或组织中组装氨基功能化的荧光标记聚糖库，将其打印为聚糖微阵列，识别被聚糖结合蛋白识别的潜在生物相关聚糖，并在结构上定义识别的聚糖。所产生的稳定库和聚糖微阵列将继续作为未来聚糖结构和功能分析的有形资源。